|
|
||||||||
European Journal of Cardio-Thoracic Surgery, Vol 8, 15-24, Copyright © 1994 by European Association for Cardio-thoracic Surgery
T Colombo, M Lanfranchi, L Passini, E Quaini, C Russo, E Vitali and A Pellegrini
From January 1982 to December 1991, 65 interventions were performed in 61
patients with active infective endocarditis (IE): 32 on native valves
(Group 1) and 33 on prosthetic valves (Group 2). In Group 1, 23 patients
had a known previous valve disease; major preoperative clinical
complications occurred in 16 patients (50%); 84% were in NYHA classes III
and IV. In Group 2 major preoperative clinical complications occurred in 13
patients (44.8%); 86% were in NYHA classes III and IV. The mean time
interval between the onset of hemodynamic impairment of varying degrees and
surgery was 13 +/- 15 days for Group 1, and 8 +/- 11 days for Group 2. In
all cases, the native valves or prostheses were replaced by mechanical
valve prostheses. Particular procedures were performed in three patients in
Group 1 and five patients in Group 2. In Group 1 there were 8 hospital
deaths (25%) and 11 (34.4%) non-fatal complications. In Group 2 there were
9 deaths (31%) and 14 (48.3%) non-fatal complications. Risk factors for
hospital death were "preoperative low cardiac output syndrome" and "time
interval between the onset of cardiac failure and surgery" in Group 1,
"cardiac failure+sepsis" in Group 2, "time interval between the onset of
cardiac failure and surgery" and "particular procedures" in all 61
patients. Sepsis alone and the type of pathogenic agent does not
significantly affect the risk of death. The recurrence of acute IE was
12.6% in Group 1, and 20% in Group 2. The incidence of reintervention was
12.6% in Group 1 and 35% in Group 2.(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Active infective endocarditis: surgical approach
A. De Gasperis Cardiac Surgery Division, Ente Ospedaliero Niguarda, Ca Granda, Milan, Italy.
This article has been cited by other articles:
![]() |
R. G. Seipelt, J. F. Vazquez-Jimenez, I. M. Seipelt, A. Franke, K. Chalabi, F. A. Schoendube, and B. J. Messmer The St. Jude ""Silzone"" valve: midterm results in treatment of active endocarditis Ann. Thorac. Surg., September 1, 2001; 72(3): 758 - 762. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. I. Awad, A. Coumbe, and R. K. Walesby Venous gangrene of the lower limbs following aortic valve replacement for native valve endocarditis Eur. J. Cardiothorac. Surg., October 1, 1999; 14(4): 440 - 442. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. F. Aranki, D. H. Adams, R. J. Rizzo, G. S. Couper, T. E. Sullivan, J. J. Collins Jr, and L. H. Cohn Determinants of Early Mortality and Late Survival in Mitral Valve Endocarditis Circulation, November 1, 1995; 92(9): 143 - 149. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |